RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Latvijas Juras Medicinas Centrs AS Stock

Latvijas Juras Medicinas Centrs AS P/S 2024

Latvijas Juras Medicinas Centrs AS P/S

0.85

Ticker

LJM1R.RG

ISIN

LV0000100741

As of Dec 12, 2024, Latvijas Juras Medicinas Centrs AS's P/S ratio stood at 0.85, a -27.97% change from the 1.18 P/S ratio recorded in the previous year.

The Latvijas Juras Medicinas Centrs AS P/S history

Latvijas Juras Medicinas Centrs AS Aktienanalyse

What does Latvijas Juras Medicinas Centrs AS do?

Latvijas Juras Medicinas Centrs AS ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Latvijas Juras Medicinas Centrs AS's P/S Ratio

Latvijas Juras Medicinas Centrs AS's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Latvijas Juras Medicinas Centrs AS's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Latvijas Juras Medicinas Centrs AS's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Latvijas Juras Medicinas Centrs AS’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Latvijas Juras Medicinas Centrs AS stock

What is the price-to-earnings ratio of Latvijas Juras Medicinas Centrs AS?

The price-earnings ratio of Latvijas Juras Medicinas Centrs AS is currently 0.85.

How has the price-earnings ratio of Latvijas Juras Medicinas Centrs AS changed compared to last year?

The price-to-earnings ratio of Latvijas Juras Medicinas Centrs AS has increased by -27.97% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Latvijas Juras Medicinas Centrs AS high compared to other companies?

Yes, the price-to-earnings ratio of Latvijas Juras Medicinas Centrs AS is high compared to other companies.

How does an increase in the price-earnings ratio of Latvijas Juras Medicinas Centrs AS affect the company?

An increase in the price-earnings ratio of Latvijas Juras Medicinas Centrs AS would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Latvijas Juras Medicinas Centrs AS affect the company?

A decrease in the price-earnings ratio of Latvijas Juras Medicinas Centrs AS would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Latvijas Juras Medicinas Centrs AS?

Some factors that influence the price-earnings ratio of Latvijas Juras Medicinas Centrs AS are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Latvijas Juras Medicinas Centrs AS pay?

Over the past 12 months, Latvijas Juras Medicinas Centrs AS paid a dividend of 0.1 EUR . This corresponds to a dividend yield of about 1.67 %. For the coming 12 months, Latvijas Juras Medicinas Centrs AS is expected to pay a dividend of 0.1 EUR.

What is the dividend yield of Latvijas Juras Medicinas Centrs AS?

The current dividend yield of Latvijas Juras Medicinas Centrs AS is 1.67 %.

When does Latvijas Juras Medicinas Centrs AS pay dividends?

Latvijas Juras Medicinas Centrs AS pays a quarterly dividend. This is distributed in the months of August, July, July, December.

How secure is the dividend of Latvijas Juras Medicinas Centrs AS?

Latvijas Juras Medicinas Centrs AS paid dividends every year for the past 7 years.

What is the dividend of Latvijas Juras Medicinas Centrs AS?

For the upcoming 12 months, dividends amounting to 0.1 EUR are expected. This corresponds to a dividend yield of 1.67 %.

In which sector is Latvijas Juras Medicinas Centrs AS located?

Latvijas Juras Medicinas Centrs AS is assigned to the 'Health' sector.

Wann musste ich die Aktien von Latvijas Juras Medicinas Centrs AS kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Latvijas Juras Medicinas Centrs AS from 12/1/2023 amounting to 0.1 EUR, you needed to have the stock in your portfolio before the ex-date on 11/29/2023.

When did Latvijas Juras Medicinas Centrs AS pay the last dividend?

The last dividend was paid out on 12/1/2023.

What was the dividend of Latvijas Juras Medicinas Centrs AS in the year 2023?

In the year 2023, Latvijas Juras Medicinas Centrs AS distributed 0.2 EUR as dividends.

In which currency does Latvijas Juras Medicinas Centrs AS pay out the dividend?

The dividends of Latvijas Juras Medicinas Centrs AS are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Latvijas Juras Medicinas Centrs AS

Our stock analysis for Latvijas Juras Medicinas Centrs AS Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Latvijas Juras Medicinas Centrs AS Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.